Syncona to Acquire Freeline Therapeutics

Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s initial pro...

November 23, 2023 | Thursday | News
AstraZeneca's Global Initiative Surpasses 1 Million Lives Touched in the Fight Against Lung Cancer

Major Milestone Met in AI-Powered Fight Against Lung Cancer Global initiative gains significant ground in digitally identifying cancer risk before s...

November 22, 2023 | Wednesday | News
Medtronic announces FDA approval of minimally invasive device to treat hypertension

Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology Medtronic plc (NYSE: MDT), a ...

November 20, 2023 | Monday | News
Vertex and CRISPR Therapeutics Granted Historic Approval for CASGEVY™, the World's First CRISPR/Cas9 Gene-Edited Therapy, by UK MHRA to Combat Sickle Cell Disease and Beta Thalassemia

 - First regulatory authorization of a CRISPR-based gene-editing therapy in the world – - CASGEVY is indicated for the treatment of sickle cell...

November 17, 2023 | Friday | News
T-Therapeutics Secures £48M in Series A for Advancing Next-Gen TCR Therapeutics in Cancer Treatment Transformation.

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofin...

November 16, 2023 | Thursday | News
£14.5 Million Funding Boost for Neurodegenerative Research Projects in the UK

Seven major research projects to receive more than £14 million to develop new tests, treatments and devices for neurodegenerative diseases includin...

November 14, 2023 | Tuesday | News
Intelligent Scopes, a Claritas HealthTech Subsidiary, Takes Charge of Global Deployment for CystoSmart™ AI Diagnostic Software in Bladder Cancer Detection

Claritas, a leader in image enhancement and AI diagnostic solutions has developed pioneering technology for real-time precision detection of conditions in ...

November 13, 2023 | Monday | News
Pfizer Advances GLP-1 Receptor Agonist PF-06954522 to Phase 1 Trial with Sosei Heptares Collaboration

Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) has been notified by Pfizer that it has entered a new oral s...

November 06, 2023 | Monday | News
Sharp acquires Berkshire Sterile Manufacturing

Sharp, a global leader in commercial pharmaceutical packaging and clinical trial supply services, has today announced the acquisition of Berkshire Ste...

October 19, 2023 | Thursday | News
Freudenberg Medical Expands Operations in Ireland, Generates 100 New Jobs

Freudenberg Medical, a leading global design and manufacturing partner for minimally invasive medical devices, has announced the creation of 100 new jobs, ...

October 04, 2023 | Wednesday | News
Oxford BioTherapeutics Announces Boehringer Ingelheim's Fast Track Status for Cancer Treatment

BI 764532 is an investigational T-cell engager that redirects T cells towards cancer cells expressing the DLL3 protein DLL3 was discovered using OBT&rsq...

October 04, 2023 | Wednesday | News
Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs The ...

September 29, 2023 | Friday | News
Pharmanovia acquires a global portfolio of products for the central nervous system (CNS) from Sanofi

- Pharmanovia acquires 11 CNS brands, including Frisium® (clobazam) and Gardenal® (phenobarbital) - The portfolio is available in more than 60 mar...

September 19, 2023 | Tuesday | News
Elastin Biosciences Unveils Breakthrough in Elastin Restoration, Promising Elastin-Deficiency Disease Treatment

After being in stealth mode for a year, Elastin Biosciences, an innovative biotech company spun off from Longaeuvus Technologies, has unveiled a groundbrea...

September 04, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in